Showing posts from October, 2017


The Ugandan LGBTIQQ Community has always decried any form of  sexual predation, as well as blackmail and extortion. But, this has been a whispered and half hearted initiative because it is said some in the LGBTIQQ leadership seem to benefit.  How? We are yet to know.  But, this we know. There are three individuals in Uganda known for being perpetual predators. They even brag about it. One is known to brag about the size of his penis; the second is known to splash money around as a lure; the third who is also known to have fancy houses and cars lures his catch by promising "lodging until the person can find their footing." This person promises a paradise too and ends up just using his catches. After which he tells all and sundry how he has made the 200th,300th,400th... catch.  Those of us in the counselling field are saddled with providing trauma counseling and the cycle continues without any leaders denouncing these people who are known to them. Most-at-R

HIV Guidelines Make Special HPV Recommendations for Gay Men

Get vaccinated for human papillomavirus (HPV) up until age 40 years of age. Gay and bisexual men with HIV should get vaccinated for human papillomavirus (HPV) up until age 40, according to  updated guidelines  from the European AIDS Clinical Society (EACS), released this week at the 16th European AIDS Conference. And others with HIV should be vaccinated until age 26, the guidelines state. "We wanted to make a strong point that patients with HIV infection, and gay men in particular, should get vaccinated," said Georg Behrens, MD, PhD, from the Hannover Medical School in Germany, who is chair of the comorbidities subcommittee of the EACS guidelines panel. This differs from the  US guidelines , which call for both men and women to be vaccinated for HPV until age 26 if they weren't vaccinated as preteens or teenagers, but make no special recommendations for gay or bisexual men. Emerging data show that HPV-related cancers are growing in prevalence in all people with

MANILA; Who is on the shortlist for Global Fund's new executive director?

We endeavor to bring you news from trustworthy sources. This time around we bring you a story authored by  Jenny Lei Ravelo of Devex. She is a senior reporter based in Manila. Since 2011, she has covered a wide range of development and humanitarian aid issues, from leadership and policy changes at DfID to the logistical and security impediments faced by international and local aid responders in disaster-prone and conflict-affected countries in Africa and Asia. Her interests include global health and the analysis of aid challenges and trends in sub-Saharan Africa. After a  difficult start  to its search for a new executive director early this year, the board of the  Global Fund to Fight AIDS, Tuberculosis and Malaria  announced Monday the latest set of candidates it is considering for the position. The list includes an eclectic mix of candidates with diverse backgrounds to replace former executive director  Mark Dybul, who stood down in May  after a four-year term. Two of the ca

Kampala, Uganda: We Remember Ivan, 27!

One day, in 2009 a group of friends talked about forming an entertaining chorus or music group. They threw around ideas but we left things to go on a burner as it were. Other issues needed to be dealt with. 12 people had HIV and needed care in form of transport and nutrition support. 24 had housing issues and 170 needed to be part of a social support network in which they could express their needs.  Among the members with whom we were discussing was Eric Lubega Ngobi who also goes by the name Ivan. Fast forward, the year is 2014, a team has just arrived in Kenya and is going through a locational cultural shock. No more familiar places like it was in Uganda! From that time on, it was new culture, new way of doing things, new languages, not many familiar faces. Even the Kenyans who studied in Uganda were distant. Perhaps because this particular group had come out as LGBTIQQ. Friends were far and apart. People relied on handouts and sex work. They also relied on well wishers wh

Kampala, Uganda: Position Your HIV Prevention Agenda to Include Participation in Clinical Trials

We bring information, to help you and your HIV Prevention organization position herself as a relevant actor in today’s changing funding priorities. There is a binary characteristic that is emerging: Prevention through information, education, communication and interventions (IECI) such as ARV-refills, HIV testing and counselling on one hand. On the other, is network building, clinical trials, criminalization and other activities that fall into a policy framework to end HIV.  There is need to be familiar with trends. Get to know how your organization can eventually fit into the Division of AIDS (DAIDS) agenda. The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic.  Toward that end, the division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related co-infections, and co-morbidities. With the ultimate goal of creating an “AIDS-Free Generation,” the

UNAIDS and UNFPA Launch Road-Map to Stop New HIV Infections

Press Release UNAIDS and UNFPA launch road map to stop new HIV infections Global HIV Prevention Coalition holds first meeting in Geneva, Switzerland, to find ways to strengthen and sustain political commitment for HIV prevention. GENEVA, 10 October 2017—As part of global efforts to end AIDS as a public health threat, UNAIDS, the United Nations Population Fund (UNFPA) and partners have launched a new road map to reduce new HIV infections. The HIV prevention 2020 road map was launched at the first meeting of the Global HIV Prevention Coalition. The coalition is chaired by the Executive Directors of UNAIDS and UNFPA and brings together United Nations Member States, civil society, international organizations and other partners as part of efforts to reduce new HIV infections by 75% by 2020. Despite progress in reducing AIDS-related deaths, which have fallen by nearly 50% since the peak of the epidemic, declines in new HIV infections among adults are lagging. While new HIV inf

Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report

Lancet HIV Sept 14 2017 -  Elske Hoornenborg, Maria Prins, Roel C A Achterbergh, Lycke R Woittiez, Marion Cornelissen, Suzanne Jurriaans, Neeltje A Kootstra,  Peter L Anderson, Peter Reiss, Henry J C de Vries, Jan M Prins, Godelieve J de Bree, on behalf of the Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Consortium (H-TEAM) Discussion We describe acquisition of infection with wild-type HIV-1 that occurred while on daily PrEP in an MSM who reported frequent condomless anal sex, indicating possibly repeated exposure to HIV. Another PrEP study 2   showed that HIV-1 infection is a rare occurrence. Our case differs from reports of HIV-1 infections in previous PrEP studies by the documentation of long-term adherence, as evidenced by repeated high tenofovir diphosphate concentrations in dried blood spots 5 ,   6   and from the two HIV-1 infections in fully adherent PrEP users by the absence of drug-resistant mutations. 8 ,   9   Althoug